Health Ministry proposes mandatory authorised person for drug batch release under the Drugs Rules, 1945
The Union Health Ministry has proposed amendments to the Drugs Rules, 1945 requiring drug manufacturers to formally designate a qualified and experienced person to authorise the release of each batch, and to keep prescribed records for every batch.
Why in news
Background: Existing manufacturing licences list technical staff for manufacturing and testing, but do not name the person authorised to release a batch to the market. The amendments aim to fix clear responsibility, ensure traceability of release decisions and strengthen Good Manufacturing Practice (GMP) compliance.
Prelims pointers
- Applicants for manufacturing licences will also have to name the person authorised for batch release.
- A prescribed format for a Batch Release Certificate is proposed.
- Objections and suggestions can be sent to the Under Secretary (Drugs Regulation), Ministry of Health and Family Welfare.
- The Drugs Rules, 1945 are framed under the Drugs and Cosmetics Act, 1940.
- The Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI), is the national drug regulator.
- Schedule M of the Drugs Rules lays down Good Manufacturing Practices. A revised Schedule M was notified in December 2023.
- Licensing of most drug manufacturing units is done by State drug controllers.
Mains angle
India supplies a large share of the world's generic medicines, so quality failures damage both public health and the country's reputation as the "pharmacy of the world". Naming a responsible person for each batch introduces accountability, similar to the "Qualified Person" system in the European Union. Its success depends on inspection capacity in States and on smaller manufacturers upgrading their quality systems.